GSIT Nasdaq Semiconductors & Related Devices Financials FY2017βFY2026
Gsi Technology Inc had $25.1M of revenue in fiscal 2026, up 22.4% on the year before. Over five years, revenue changed β2.0% a year on average.
Last close Β· Oct 23, 2026
$3.86
0.0%Hi! I read Gsi Technology Incβs latest annual report (fiscal 2026). Here is what stands out:
Good So-so Weak
Are sales growing?
+22.4%
Yes. Sales grew 22.4% last year.
Does it make a profit?
β52.7%
No. It lost money last year.
Does profit turn into cash?
β65.3%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Gsi Technology Inc did it, and the next one. Share prices often move a lot on those days.
Next results
November 5, 2026
Thursday Β· in 11 days
No past results dates on file yet.
KIRA Β· Gsi Technology Inc had $25.1M of revenue in fiscal 2026, up 22.4% on the year before. Over five years, revenue changed β2.0% a year on average. Its operating margin was β69.6%, down 16.8Β pts: of every 100 in sales, about β70 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
KIRA Β· Gsi Technology Inc lost $13.2M in fiscal 2026.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$16.4M in fiscal 2026, β65.3% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Gsi Technology Inc can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $44.0M | $30.6M | $14.4M | $13.4M | $67.2M |
| Current ratio | 6.2x | 5.8x | 5.6x | 3.3x | 8.6x |
| Quick ratio | 5.6x | 4.9x | 4.7x | 2.8x | 8.2x |
| Total assets | $76.4M | $59.9M | $42.5M | $43.3M | $98.0M |
| Total liabilities | $12.0M | $8.5M | $6.5M | $15.1M | $16.2M |
| Shareholders' equity | $64.5M | $51.4M | $36.0M | $28.2M | $81.8M |
| Net debt (β = net cash) | β | β | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
KIRA Β· Gsi Technology Inc passes 3 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 8 | 6 / 8 | 3 / 8 | 1 / 8 | 4 / 8 | 2 / 8 | 2 / 8 | 1 / 8 | 3 / 8 |
| Accruals ratio | β2.1% | β5.5% | β2.8% | β5.4% | β6.6% | β3.1% | 1.3% | β5.3% | 5.4% | 3.8% |
| Altman Z'' | 11.34 | 13.02 | 13.54 | 12.68 | 10.20 | 8.64 | 8.12 | 4.52 | 0.11 | 7.18 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $48.2M | $42.6M | $51.5M | $43.3M | $27.7M | $33.4M | $29.7M | $21.8M | $20.5M | $25.1M |
| Gross profit | $26.4M | $22.4M | $31.6M | $25.3M | $13.2M | $18.5M | $17.7M | $11.8M | $10.1M | $13.7M |
| Research and development | $15.8M | $17.0M | $21.4M | $25.2M | $23.3M | $24.7M | $23.6M | $21.7M | $16.0M | $19.9M |
| Operating income | β$0.5M | β$4.5M | β$0.2M | β$10.8M | β$21.3M | β$16.4M | β$15.8M | β$20.4M | β$10.8M | β$17.5M |
| Pretax income | β$0.0M | β$4.1M | $0.3M | β$10.1M | β$21.2M | β$16.4M | β$15.6M | β$20.0M | β$10.5M | β$13.4M |
| Income tax | $0.1M | $0.5M | $0.1M | $0.2M | $0.3M | β$0.0M | $0.4M | $0.1M | $0.1M | β$0.1M |
| Net income | β$0.1M | β$4.5M | $0.2M | β$10.3M | β$21.5M | β$16.4M | β$16.0M | β$20.1M | β$10.6M | β$13.2M |
| Net income to common | β$0.1M | β$4.5M | $0.2M | β$10.3M | β$21.5M | β$16.4M | β$16.0M | β$20.1M | β$10.6M | β$13.2M |
| Diluted EPS | β$0.01 | β$0.21 | $0.01 | β$0.45 | β$0.91 | β$0.67 | β$0.65 | β$0.80 | β$0.42 | β$0.42 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $2.1M | $1.1M | $3.0M | β$4.7M | β$15.3M | β$13.8M | β$16.8M | β$17.4M | β$13.0M | β$15.9M |
| Capital expenditure | $0.2M | $1.3M | $2.1M | $0.3M | $0.2M | $0.8M | $0.3M | $0.6M | $0.0M | $0.5M |
| Free cash flow | $1.8M | β$0.3M | $0.9M | β$5.0M | β$15.5M | β$14.6M | β$17.2M | β$18.0M | β$13.0M | β$16.4M |
| Depreciation and amortization | $1.5M | $1.3M | $1.5M | $1.4M | $1.2M | $1.0M | $1.0M | $0.9M | $0.7M | $0.6M |
| Stock-based compensation | $1.9M | $2.1M | $2.3M | $2.6M | $2.9M | $3.0M | $2.5M | $2.8M | $2.3M | $2.8M |
| Share buybacks | $7.1M | β | $0.1M | β | β | β | β | β | β | β |
| Dividends and buybacks | $7.1M | β | $0.1M | β | β | β | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $33.7M | $58.4M | $61.8M | $66.6M | $54.0M | $44.0M | $30.6M | $14.4M | $13.4M | $67.2M |
| Current assets | $68.3M | $71.3M | $77.4M | $79.1M | $63.4M | $54.7M | $41.9M | $30.1M | $23.5M | $79.2M |
| Current liabilities | $10.5M | $7.4M | $8.7M | $8.3M | $7.5M | $8.9M | $7.2M | $5.4M | $7.1M | $9.2M |
| Inventory | $9.2M | $5.5M | $5.7M | $4.3M | $4.3M | $4.7M | $6.4M | $5.0M | $3.9M | $4.1M |
| Property and equipment, net | $7.7M | $8.2M | $9.0M | $8.1M | $7.3M | $7.4M | $7.4M | $1.1M | $0.8M | $0.9M |
| Goodwill | $8.0M | $8.0M | $8.0M | $8.0M | $8.0M | $8.0M | $8.0M | $8.0M | $8.0M | $8.0M |
| Intangible assets | $3.3M | $3.0M | $2.7M | $2.5M | $2.3M | $2.0M | $1.8M | $1.6M | $1.3M | $1.1M |
| Total assets | $103M | $99.5M | $106M | $103M | $87.6M | $76.4M | $59.9M | $42.5M | $43.3M | $98.0M |
| Total liabilities | $16.2M | $12.7M | $13.1M | $12.9M | $12.0M | $12.0M | $8.5M | $6.5M | $15.1M | $16.2M |
| Shareholders' equity | $86.4M | $86.8M | $93.2M | $89.6M | $75.6M | $64.5M | $51.4M | $36.0M | $28.2M | $81.8M |
| Margins | ||||||||||
| Gross margin | 54.8% | 52.6% | 61.4% | 58.5% | 47.7% | 55.5% | 59.6% | 54.3% | 49.4% | 54.5% |
| Operating margin | β1.1% | β10.5% | β0.4% | β24.9% | β76.7% | β49.0% | β53.2% | β93.9% | β52.8% | β69.6% |
| EBITDA margin | 2.1% | β7.5% | 2.5% | β21.6% | β72.3% | β46.0% | β49.8% | β89.6% | β49.6% | β67.1% |
| Net margin | β0.2% | β10.6% | 0.3% | β23.8% | β77.6% | β49.0% | β53.8% | β92.3% | β51.9% | β52.7% |
| FCF margin | 3.8% | β0.6% | 1.8% | β11.6% | β55.7% | β43.7% | β57.8% | β82.7% | β63.5% | β65.3% |
| Returns | ||||||||||
| Return on capital employed | β0.6% | β4.9% | β0.2% | β11.5% | β26.5% | β24.2% | β30.0% | β55.1% | β29.9% | β19.7% |
| Return on equity | β0.1% | β5.2% | 0.2% | β11.3% | β26.0% | β23.4% | β27.6% | β46.0% | β33.1% | β24.1% |
| Return on assets | β0.1% | β4.5% | 0.2% | β9.9% | β22.6% | β20.0% | β23.4% | β39.3% | β24.8% | β18.8% |
| Return on tangible equity | β0.2% | β6.0% | 0.2% | β13.1% | β32.9% | β30.1% | β38.4% | β76.0% | β56.2% | β18.2% |
| Growth | ||||||||||
| Revenue growth | β | β11.5% | 20.7% | β15.8% | β36.0% | 20.4% | β11.1% | β26.7% | β5.7% | 22.4% |
| Net income growth | β | β | β | β6,441.7% | β | β | β | β | β | β |
| EPS growth | β | β | β | β4,600.0% | β | β | β | β | β | β |
| FCF growth | β | β113.9% | β | β647.2% | β | β | β | β | β | β |
| Share count change | β | 2.1% | 10.7% | β1.6% | 3.1% | 2.7% | 1.2% | 2.2% | 1.4% | 24.9% |
| Financial health | ||||||||||
| Current ratio | 6.5x | 9.6x | 8.9x | 9.6x | 8.5x | 6.2x | 5.8x | 5.6x | 3.3x | 8.6x |
| Quick ratio | 5.6x | 8.9x | 8.2x | 9.1x | 7.9x | 5.6x | 4.9x | 4.7x | 2.8x | 8.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.5% | 3.1% | 4.1% | 0.8% | 0.7% | 2.3% | 1.1% | 3.0% | 0.2% | 1.9% |
| Stock comp / revenue | 3.9% | 4.9% | 4.4% | 5.9% | 10.3% | 9.0% | 8.3% | 13.0% | 11.0% | 11.2% |
| Payouts / FCF | 387.8% | β | 11.2% | β | β | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 6.0 | 3.0 | 1.0 | 4.0 | 2.0 | 2.0 | 1.0 | 3.0 |
| Altman Z'' | 11.3 | 13.0 | 13.5 | 12.7 | 10.2 | 8.6 | 8.1 | 4.5 | 0.1 | 7.2 |
| Accruals ratio | β2.1% | β5.5% | β2.8% | β5.4% | β6.6% | β3.1% | 1.3% | β5.3% | 5.4% | 3.8% |
Source: SEC EDGAR XBRL filings (CIK 0001126741). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
